论文信息 - Preclinical efficacy, safety, and immunogenicity of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 - 字舞流文

Preclinical efficacy, safety, and immunogenicity of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

J. Barretina | B. Clotet | J. Segalés | J. Prado | S. Marfil | A. Meyerhans | J. Blanco | J. Vergara-Alert | A. Prenafeta | A. Moros | G. Bech-Sàbat | J. Pedroza | C. Lorca-Oró | Jordi | Antonio Barreiro | Rosa | Edwards Pradenas | Benjamin | M. Roca | Cabañas | Mónica Pérez | Marta Sisteré-Oró | Leira Fernández-Bastit | R. March | E. Perozo | Clara Panosa | Núria Roca | Jordina Loubat-Casanovas | Alberto Moreno | R. Ortiz | E. Vilarrassa | Larripa | Laia Madrenas | A. Fernández | Jordi Palmada | Carme Garriga | Paula Cebollada Rica | Luis González | Sara Capdevila | A. Moreno | T. Prat | M. Molas | Laura Ferrer | J. Corominas | Mur | T. Pelegrin | Ester Puigvert Molas | Rodon | Trinité | Ampudia Carrasco | Yaiza Rosales Salgado